Skip to main content
Premium Trial:

Request an Annual Quote

Sciex, Waters Partner to Provide Interoperable LC-MS Systems

NEW YORK – Sciex and Waters said on Tuesday that they are partnering to offer customers Sciex mass spectrometry systems fully configured and interoperable with Waters liquid chromatography instruments.

The collaboration will make it easier for Sciex mass spec customers to configure their systems with Waters' UPLC instruments, which can provide increased mass spec sensitivity for the detection and quantification of low abundance analytes.

The two companies have developed instrument control drivers that allow Sciex's OS software to directly control Waters Acquity UPLC I-Class Plus Systems, as well as the H-Class Plus, H-Class Plus Bio, and M-Class instruments.

"We strive to provide the best products and services, and live by the mantra, 'when customers talk, we listen,'" Dom Gostick, VP and general manager of LC-MS and chief technology officer at Sciex, said in a statement. "Through this collaboration, we are broadening the variety of LC instruments available to our growing customer base."

"Scientists will immediately benefit from ease of access to industry-leading UPLC systems," said Jon Pratt, senior VP at Waters. "This agreement provides for a smooth, integrated experience for customers with the coordinated support of Waters’ expertise and service."

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.